论文部分内容阅读
目的研究中西药结合治疗胆囊炎的临床应用优势。方法 88例胆囊炎患者,随机分为西药组和中西药组,各44例。西药组给予常规对症支持加西药治疗,中西药组给予常规对症支持加中西药结合治疗。比较两组治疗后的效果,治疗前后肿瘤坏死因子-α、白细胞介素-1β、C反应蛋白的差异。结果中西药组总有效率为95.45%,高于西药组的72.73%,差异有统计学意义(P<0.05)。治疗前两组肿瘤坏死因子-α、白细胞介素-1β、C反应蛋白指标比较差异无统计学意义(P>0.05);治疗后中西药组肿瘤坏死因子-α、白细胞介素-1β、C反应蛋白指标改善情况优于西药组,差异有统计学意义(P<0.05)。结论中西药结合治疗胆囊炎的临床应用效果确切,可有效改善临床症状,降低机体炎症水平,值得推广。
Objective To study the clinical application advantages of combining Chinese and western medicine in the treatment of cholecystitis. Methods 88 cases of cholecystitis were randomly divided into western medicine group and western medicine group, 44 cases in each. Western medicine group to give conventional symptomatic treatment of Western medicine, traditional Chinese and Western medicine group to give conventional symptomatic support plus Western medicine treatment. The effects of the two groups were compared before and after treatment, tumor necrosis factor-α, interleukin-1β, C-reactive protein differences. Results The total effective rate of Chinese and western medicine was 95.45%, which was higher than that of western medicine group (72.73%), the difference was statistically significant (P <0.05). There were no significant differences in the levels of tumor necrosis factor-α, interleukin-1β and C-reactive protein between the two groups before treatment (P> 0.05). After treatment, the levels of tumor necrosis factor-α, interleukin- The improvement of reactive protein index was better than Western medicine group, the difference was statistically significant (P <0.05). Conclusion Clinical application of traditional Chinese and western medicine in the treatment of cholecystitis is effective, which can effectively improve the clinical symptoms and reduce the level of inflammation in the body and is worth promoting.